Search results
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Bokf Na
ETF DAILY NEWS· 1 day agoBokf Na lessened its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 20.0% during the 4th quarter, according to its most recent 13F filing with the ...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Morningstar· 3 days agoThe Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Biogen
Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to...
Morningstar· 3 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 3 days agoDo you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.
...Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with...
Benzinga· 6 days agoThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biogen Inc. ("< ...
...Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm - Charge Enterprises Inc...
Benzinga· 4 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen
Research Analysts Set Expectations for Biogen Inc.’s FY2027 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Analysts at Wedbush lowered their FY2027 earnings estimates for Biogen in a research report ...
Prudential PLC Cuts Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoPrudential PLC decreased its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.4% during the 4th quarter, according to the company in ...
Petri Dish: Ipsen’s drug approval; Discovery expands local footprint - Boston Business Journal
The Business Journals· 10 hours agoOn Monday, an FDA advisory committee unanimously voted in favor of donanemab, Eli Lilly’s treatment...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoTOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: ...